Altered neurotrophin, neuropeptide, cytokines and nitric oxide levels in autism

Pharmacopsychiatry

Volumn 45, Issue 6, 2012, Pages 241-243

  Tostes, M H F S ^a   Teixeira, H C ^a   Gattaz, W F ^b   Brandao M A F ^a   Raposo, N R B ^a,b  

^a FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

autism; children; cytokines; nitric oxide; NT 3; VIP

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; NEUROPEPTIDE; NEUROTROPHIN; NEUROTROPHIN 3; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA; VASOACTIVE INTESTINAL POLYPEPTIDE;

ARTICLE; AUTISM; CHEMICAL ANALYSIS; CHEMICAL REACTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DSM-IV; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GRIESS REACTION; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

AUTISTIC DISORDER; CASE-CONTROL STUDIES; CHILD; CYTOKINES; FEMALE; HUMANS; INTERFERON-GAMMA; MALE; NEUROTROPHIN 3; NITRIC OXIDE; VASOACTIVE INTESTINAL PEPTIDE;

EID: 84866357256     PISSN: 01763679     EISSN: 14390795     Source Type: Journal    
DOI: 10.1055/s-0032-1301914     Document Type: Article

References (34)

1. Chauhan A, Chauhan V. Oxidative stress in autism. Pathophysiology: 2006; 13 171 181
2. Sweeten T L, Posey D J, Shankar S et al. High nitric oxide production in autistic disorder: a possible role for interferon-gamma. Biol Psychiatry: 2004; 55 434 437 (Pubitemid 38199995)
3. Lonart G, Wang J, Johnson K M. Nitric oxide induces neurotransmitter release from hippocampal slices. Eur J Pharmacol: 1992; 220 271 272
4. Hindley S, Juurlink B H, Gysbers J W et al. Nitric oxide donors enhance neurotrophin-induced neurite outgrowth through a cGMP-dependent mechanism. J Neurosci Res: 1997; 47 427 439 (Pubitemid 27097757)
5. Truman J W, De Vente J, Ball E E. Nitric oxide-sensitive guanylate cyclase activity is associated with the maturational phase of neuronal development in insects. Development: 1996; 122 3949 3958
6. Hölscher C, Rose S P. An inhibitor of nitric oxide synthesis prevents memory formation in the chick. Neurosci Lett: 1992; 145 165 167
7. Brenneman D E, Eiden L E. Vasoactive Intestinal Peptide and electrical activity influence neuronal survival. Proc Natl Acad Sci USA: 1986; 83 1159 1162 (Pubitemid 16086432)
8. Brenneman D E, Gozes I. A femtomolar-acting neuroprotective peptide. J Clin Invest: 1996; 97 2299 2307 (Pubitemid 26165719)
9. Nelson K B, Grether J K, Croen L A et al. Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Ann Neurol: 2001; 49 597 606 (Pubitemid 32429787)
10. Castrén E, Võikar V, Rantamäki T. Role of neurotrophic factors in depression. Curr Opin Pharmacol: 2007; 7 18 21 (Pubitemid 46238033)
11. Segal R A. Selectivity in neurotrophin signaling: theme and variations. Ann Rev Neurosci: 2003; 26 299 330 (Pubitemid 37064936)
12. Kovalchuk Y, Holthoff K, Konnerth A. Neurotrophin action on a rapid timescale. Curr Opin Neurobiol: 2004; 14 558 563 (Pubitemid 39349616)
13. nd General Assembly WMA: 2000
14. APA - American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR. Washington American Psychiatric Association: 1994
15. Green L C, Wagner D A, Glogowsk J et al. Analysis of nitrate, nitrite and nitrate in biological fluids. Anal Biochem: 1982; 126 131 138 (Pubitemid 13203451)
16. Nelson P G, Kuddo T, Song E Y et al. Selected neurotrophins, neuropeptides, and cytokines: developmental trajectory and concentrations in neonatal blood of children with autism or Down syndrome. Int J Devel Neurosci: 2006; 24 73 80 (Pubitemid 43287950)
17. Sajdel-Sulkowska E, Ming X, Koibuchi N. Increase in cerebellar neurotrophin-3 and oxidative stress markers in autism. Cerebellum: 2009; 8 366 372
18. Pan W, Banks W A, Fasold M B et al. Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology: 1998; 37 1553 1561 (Pubitemid 28550429)
19. Sajdel-Sulkowska E. Oxidative stress and neurotrophin signaling in autism. In: Chauhan A, Chauhan V, Brown T. (eds.). Autism: Oxidative stress, Inflammation and Immune abnormalities (47-60). New York CRC Press: 2010
20. Sherrard R M, Bower A J. Climbing fibre development: do neurotrophins have a part to play? Cerebellum: 2002; 1 262 275
21. Blondel O, Collin C, McCarran B et al. A glia-derived signal regulating neuronal differentiation. J Neurosci: 2000; 2 8012 8020
22. Fernandes B S, Gama C S, Walz J C et al. Increased neurotrophin-3 in drug-free subjects with bipolar disorder during manic and depressive episodes. J Psychiatry Res: 2010; 44 561 565
23. Duman R S, Monteggia L M. A neurotrophic model for stress-related mood disorders. Biol Psychiatry: 2006; 59 1116 1127
24. Kato A, Fukuzawa Y, Ozawa I et al. Activation of ERK cascade promotes accumulation of Vesi1S/Homer-1a immunoreactivity at synapses. Mol Brain Res: 2003; 118 33 34
25. Agerman K, Ernfors P. Differential influence of BDNF and NT3 on the expression of calcium binding proteins and neuropeptide Y in vivo. NeuroReport: 2003; 14 2183 2187
26. Schutte A, Yan Q, Mestres P et al. The endogenous survival promotion of axotomized rat corticospinal neurons by brain-derived neurotrophic factor is mediated via paracrine, rather than autocrine mechanisms. Neurosci Lett: 2000; 290 185 188 (Pubitemid 30645863)
27. Giehl K M, Röhrig S, Bonatz H et al. Endogenous brain-derived neurotrophic factor and neurotrophin-3 antagonistically regulate survival of axotomized corticospinal neurons in vivo. J Neurosci: 2001; 21 3492 3502 (Pubitemid 32422813)
28. Nelson P G, McCune S K, Ades A M et al. Glial-neurotrophic mechanisms in Down syndrome. J Neural Transm: 2001; 61 Suppl 85 94 (Pubitemid 38085074)
29. Brenenman D E, Hauser J, Phillips T M et al. Vasoactive Intestinal Peptide: link between electrical activity and glia-mediated neurotrophism. Ann N Y Acad Sci: 1999; 897 17 26 (Pubitemid 30040316)
30. Tran M T, Ritchie M H, Lausch R N et al. Calcitonin gene-related peptide induces IL-8 synthesis in corneal epithelial cells. J Immunol: 2000; 164 4307 4312 (Pubitemid 30215093)
31. Delgado M, Ganea D. Vasoactive intestinal peptide inhibits IL-8 production in human monocytes by down regulation nuclear factor kappa B-dependent transcriptional activity. Biochem Biophys Res Commun: 2003; 302 275 283 (Pubitemid 36397917)
32. Croonenberghs J, Bosmans E, Deboutte D et al. Activation of the inflammatory response system in autism. Neuropsychobiology: 2002; 45 1 6 (Pubitemid 34117721)
33. Jyonouchi H, Sun S. Proinflammatory and regulatory cytokine production associated with innate and adaptative immune responses in children with autism spectrum disorders and developmental regression. J Neuroimmunol: 2001; 120 170 179 (Pubitemid 33016737)
34. Zorolu S S, Yürekli M, Meram I et al. Pathophysiological role of nitric oxide and adrenomedullin in autism. Cell Biochem Funct: 2003; 21 55 60 (Pubitemid 36227827)